Skopos Labs, Inc. Dexcom Inc Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,997 shares of DXCM stock, worth $116,265. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,997
Previous 1,997
-0.0%
Holding current value
$116,265
Previous $136,000
27.94%
% of portfolio
0.04%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding DXCM
# of Institutions
1,106Shares Held
366MCall Options Held
5.36MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$2.81 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.01 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$981 Million0.06% of portfolio
-
Baillie Gifford & CO15.9MShares$925 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$627 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...